Parmax Pharma Ltd vs Syschem India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Parmax Pharma Ltd is ₹ 30.02 as of 30 Apr 15:30 . The P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Syschem (India) Ltd changed from 33.7 on March 2023 to 332.4 on March 2025 . This represents a CAGR of 114.46% over 3 years The Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2021 to ₹ 15.8 crore on March 2025 . This represents a CAGR of 3.54% over 5 yearsThe Market Cap of Syschem (India) Ltd changed from ₹ 16.16 crore on March 2021 to ₹ 159.08 crore on March 2025 . This represents a CAGR of 57.99% over 5 years The revenue of Parmax Pharma Ltd for the Dec '25 is ₹ 4.33 crore as compare to the Sep '25 revenue of ₹ 2.54 crore. This represent the growth of 70.47% The revenue of Syschem (India) Ltd for the Dec '25 is ₹ 141.5 crore as compare to the Sep '25 revenue of ₹ 103.61 crore. This represent the growth of 36.57% The ebitda of Parmax Pharma Ltd for the Dec '25 is ₹ -0.19 crore as compare to the Sep '25 ebitda of ₹ -1.58 crore. This represent the decline of -87.97% The ebitda of Syschem (India) Ltd for the Dec '25 is ₹ 5.96 crore as compare to the Sep '25 ebitda of ₹ 3.31 crore. This represent the growth of 80.06% The net profit of Parmax Pharma Ltd changed from ₹ 0.01 crore to ₹ -0.73 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Syschem (India) Ltd changed from ₹ 0.14 crore to ₹ 4.17 crore over 7 quarters. This represents a CAGR of 595.49% The Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Syschem (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Parmax Pharma Ltd

Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

About Syschem (India) Ltd

Syschem (India) Limited, formerly known as Anil Pesticides Limited was incorporated on 31 December, 1993.
The name of the Company was changed from Anil Pesticides Limited to Syschem (India) Limited on February 17, 2003.
Company is engaged in the business of manufacturing of API / Intermediates.
It has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt.
Panchkula (Haryana). In 1996 the company went for launching new product called Monocrotophos and production was commissioned in 1998. The company expanded the installed capacity of Dichlorvos by 400 TPM in 2000. The company introduced new products namely Deta,DETC and Ethion in 2001.

FAQs for the comparison of Parmax Pharma Ltd and Syschem (India) Ltd

Which company has a larger market capitalization, Parmax Pharma Ltd or Syschem (India) Ltd?

Market cap of Parmax Pharma Ltd is 11 Cr while Market cap of Syschem (India) Ltd is 253 Cr

What are the key factors driving the stock performance of Parmax Pharma Ltd and Syschem (India) Ltd?

The stock performance of Parmax Pharma Ltd and Syschem (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Parmax Pharma Ltd and Syschem (India) Ltd?

As of May 3, 2026, the Parmax Pharma Ltd stock price is INR ₹30.02. On the other hand, Syschem (India) Ltd stock price is INR ₹51.78.

How do dividend payouts of Parmax Pharma Ltd and Syschem (India) Ltd compare?

To compare the dividend payouts of Parmax Pharma Ltd and Syschem (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.